Evidence map›Paper›PMID 36139662›Full record

ReviewCancers2022

Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis.

Ranakul Islam, Lei Zhao, Yifang Wang, Grace Lu-Yao, Ling-Zhi Liu

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  7. Review
  8. E-Cigarette effects on oral health: A molecular perspective.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Bioaccumulation Capacity of Onion (Molecules (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ranakul IslamDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0001-9384-3231
Lei ZhaoDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Yifang WangDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Grace Lu-YaoDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0002-2925-7737
Ling-Zhi LiuDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0001-9234-457X

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatmentsR01CA232587 · NCI · UNIVERSITY OF IOWA · PI SIMONE, NICOLE L · 2018 to 2022
$2.9M
MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment responseR01CA263506 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Jun He · 2022 to 2026
$2.8M
METTL3 in chromium-induced angiogenesis and carcinogenesisR01ES033197 · NIEHS · THOMAS JEFFERSON UNIVERSITY · PI STEVEN B. MCMAHON · 2022 to 2026
$2.6M
New Mechanism of Arsenic CarcinogenesisK02ES029119 · NIEHS · UNIVERSITY OF IOWA · PI LIU, LING-ZHI · 2018 to 2022
$613k
American Cancer Society NEC-129306Commonwealth University Research Enhancement Program grant with the Pennsylvania De-partment of Health SAP#4100088563NCI NIH HHS P30 CA056036NCI NIH HHS R01 CA232587NCI NIH HHS R01CA232587NCI NIH HHS R01 CA263506NCI NIH HHS R01CA263506NIEHS NIH HHS K02 ES029119NIEHS NIH HHS K02ES029119NIEHS NIH HHS R01 ES033197NIEHS NIH HHS R01ES033197
6 · The paper itself

Abstract

Arsenic is a crucial environmental metalloid whose high toxicity levels negatively impact human health. It poses significant health concerns to millions of people in developed and developing countries such as the USA, Canada, Bangladesh, India, China, and Mexico by enhancing sensitivity to various types of diseases, including cancers. However, how arsenic causes changes in gene expression that results in heinous conditions remains elusive. One of the proposed essential mechanisms that still has seen limited research with regard to causing disease upon arsenic exposure is the dysregulation of epigenetic components. In this review, we have extensively summarized current discoveries in arsenic-induced epigenetic modifications in carcinogenesis and angiogenesis. Importantly, we highlight the possible mechanisms underlying epigenetic reprogramming through arsenic exposure that cause changes in cell signaling and dysfunctions of different epigenetic elements.

Indexed as

angiogenesisarseniccarcinogenesisepigenetic regulation

Identifiers

PMID36139662
PMCPMC9496897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.